Cultivate(Md) Capital Funds Announces Portfolio Company Embody'S Acquisition By Zimmer Biomet Holdings, Inc.
Cultivate(Md) Capital Funds Announces Portfolio Company Embody'S Acquisition By Zimmer Biomet Holdings, Inc.
01/10/23, 12:02 PM
Location
warsawIndustry
artificial intelligence
health care
information technology
medical
biotechnology
health care
cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage healthcare companies with innovative technologies, announced today that one of their portfolio companies, Norfolk, VA-based Embody, Inc., a privately held medical device company focused on soft tissue healing, has reached an agreement with Zimmer Biomet Holdings, Inc., a global leader in medical technology, to be acquired. The terms of the acquisition include $155 million at closing and up to an additional $120 million based on achieving future milestones over the next three years.
Company Info
Location
Warsaw, Indiana, United States
Company info
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.
With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.
For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com or follow Zimmer Biomet on Twitter at www.twitter.com/zimmerbiomet.